Correlation Between Zivo Bioscience and Oxford Cannabinoid
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on Zivo Bioscience and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Oxford Cannabinoid.
Diversification Opportunities for Zivo Bioscience and Oxford Cannabinoid
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zivo and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Oxford Cannabinoid go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Oxford Cannabinoid
Given the investment horizon of 90 days Zivo Bioscience is expected to under-perform the Oxford Cannabinoid. But the stock apears to be less risky and, when comparing its historical volatility, Zivo Bioscience is 6.76 times less risky than Oxford Cannabinoid. The stock trades about -0.02 of its potential returns per unit of risk. The Oxford Cannabinoid Technologies is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 0.51 in Oxford Cannabinoid Technologies on September 2, 2024 and sell it today you would lose (0.23) from holding Oxford Cannabinoid Technologies or give up 45.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.05% |
| Values | Daily Returns |
Zivo Bioscience vs. Oxford Cannabinoid Technologie
Performance |
| Timeline |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Oxford Cannabinoid |
Zivo Bioscience and Oxford Cannabinoid Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zivo Bioscience and Oxford Cannabinoid
The main advantage of trading using opposite Zivo Bioscience and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
| Oxford Cannabinoid vs. Rigel Pharmaceuticals | Oxford Cannabinoid vs. Geron | Oxford Cannabinoid vs. Verastem | Oxford Cannabinoid vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |